Hero Image

Mildly Reduced Ejection Fraction (HFmrEF): Patient Guide

Mildly reduced ejection fraction (HFmrEF) sits between normal heart pumping function and more severe forms of heart failure.

In this friendly guide, you’ll learn what HFmrEF means, how to recognize warning signs, why early action matters, and which treatments and lifestyle changes can help you feel and live better.

What is mildly reduced ejection fraction (HFmrEF)?

Your ejection fraction (EF) is the percentage of blood your heart’s left ventricle pumps out with each beat. A normal EF is usually 50–70%. When EF drops, the heart may not circulate blood as effectively. HFmrEF typically refers to an EF of about 41–49%, a middle ground between heart failure with preserved EF (HFpEF) and heart failure with reduced EF (HFrEF). You can read more about EF from the American Heart Association.

The term HFmrEF is helpful because people in this range often share features of both HFpEF and HFrEF, and many benefit from guideline-directed therapies. Importantly, EF is only part of the picture—heart failure is a clinical syndrome of symptoms and signs caused by cardiac dysfunction. Clinicians use EF along with symptoms, exam findings, and tests to confirm the diagnosis. Current definitions and care recommendations are detailed in the 2022 AHA/ACC/HFSA Heart Failure Guideline.

EF is most commonly measured by an echocardiogram (heart ultrasound), a quick, noninvasive test that shows how well your heart squeezes and relaxes. Learn more about echo testing from the AHA. Other tests—such as cardiac MRI—can refine EF and uncover underlying causes like scar or inflammation; see an overview of cardiac MRI from RadiologyInfo.org. For the formal heart failure definition, including the role of biomarkers and imaging, review the Universal Definition of Heart Failure.

Why recognizing signs and symptoms early matters

Spotting HFmrEF symptoms early can prevent fluid buildup, reduce hospitalizations, and protect long-term heart function. When treated promptly with the right therapies, many people improve their symptoms, exercise capacity, and quality of life.

Research shows several medications lower the risk of heart failure flare-ups and cardiovascular events across a broad range of EF. For example, SGLT2 inhibitors reduced heart failure hospitalizations in people with EF above 40% in the EMPEROR-Preserved and DELIVER trials. Early evaluation also helps find reversible causes—like uncontrolled blood pressure or coronary artery disease—so they can be treated before damage worsens.

Common signs and symptoms of HFmrEF

Symptoms vary, and not everyone has all of them. Contact your clinician if you notice new or worsening:

  • Shortness of breath (especially with activity, lying flat, or at night)
  • Unusual fatigue or reduced exercise tolerance
  • Swelling in legs, ankles, or abdomen (edema)
  • Rapid weight gain (e.g., 2–3 pounds in a day or 5 pounds in a week)
  • Persistent cough or wheeze, especially at night
  • Chest discomfort or palpitations (fast or irregular heartbeat)
  • Dizziness, lightheadedness, or near-fainting
  • Loss of appetite, early fullness, or abdominal bloating

Keep a simple symptom and weight diary. Bring notes to appointments so your care team can adjust your plan quickly. If you experience severe shortness of breath, chest pain, fainting, or bluish lips, call emergency services immediately. Review urgent warning signs from the AHA.

How HFmrEF is diagnosed

Diagnosis blends your history, a physical exam, and targeted tests:

  • Echocardiogram: Measures EF (41–49% suggests HFmrEF in the right clinical context) and evaluates valve function and chamber size.
  • Blood tests: Natriuretic peptides (BNP or NT-proBNP) support the diagnosis when elevated; see an overview on BNP/NT-proBNP.
  • ECG and chest X-ray: Look for rhythm problems, heart enlargement, or fluid in the lungs.
  • Stress testing and coronary evaluation: If symptoms or risk factors suggest blocked arteries, your team may order a stress test or coronary imaging; learn more about coronary disease at the NHLBI.
  • Cardiac MRI or advanced imaging: Clarifies EF and identifies scarring, inflammation, or infiltrative diseases when needed.

Treatments and therapies that work for HFmrEF

Core medications

  • SGLT2 inhibitors: Empagliflozin and dapagliflozin reduce heart failure hospitalizations across EF ranges, including HFmrEF, as shown in EMPEROR-Preserved and DELIVER. They are now recommended in major guidelines.
  • ACE inhibitors or ARBs, and ARNI: These lower blood pressure, reduce strain on the heart, and can improve outcomes in many patients. Read more on ACE inhibitors/ARBs and ARNI.
  • Evidence-based beta blockers: Carvedilol, metoprolol succinate, or bisoprolol slow the heart and improve function over time; see the AHA overview on beta blockers.
  • Mineralocorticoid receptor antagonists (MRAs): Spironolactone or eplerenone can help selected patients, especially with persistent congestion or high BNP; learn more about MRAs.
  • Diuretics: Loop diuretics relieve fluid buildup and ease breathing; see the AHA guide to diuretics. Your dose may change based on daily weights and symptoms.

Your clinician will tailor therapy to your EF, blood pressure, kidney function, electrolytes, and other conditions. Starting low and slowly increasing doses helps minimize side effects. For detailed, clinician-facing recommendations, see the AHA/ACC/HFSA guideline and the 2021 ESC Heart Failure Guideline.

Manage contributing conditions

  • High blood pressure: Tight control prevents further heart muscle strain.
  • Coronary artery disease: If blockages are present, revascularization may improve symptoms and function; learn about coronary disease from the NHLBI.
  • Atrial fibrillation: Rhythm or rate control and anticoagulation (when indicated) are crucial; see AHA resources on AFib.
  • Diabetes, kidney disease, obesity, and sleep apnea: Treating these can markedly improve heart failure symptoms. Learn about sleep apnea at the NHLBI.

Devices and procedures

  • Implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy (CRT): These are usually for EF ≤35% with specific criteria. Some people fluctuate around the HFmrEF range; your team will reassess EF after optimized therapy.
  • Valve repair/replacement: Treating significant valve disease can improve EF and symptoms.
  • Coronary procedures: Stents or bypass surgery may be recommended when arteries are narrowed and symptoms or testing support a benefit.

Lifestyle and self-care

  • Daily weights: Weigh yourself every morning after urinating, before breakfast, and log it. Sudden gains often mean fluid buildup; see the AHA’s guide to daily weight tracking.
  • Smart sodium and fluids: Many people do well limiting sodium to about 1,500–2,000 mg/day and fluids to 1.5–2 liters/day if you’re fluid-overloaded—confirm your targets with your clinician. Get practical sodium-reduction tips from the CDC.
  • Move more, safely: Regular, moderate activity improves stamina and mood. Ask about cardiac rehab and an individualized exercise plan for heart failure.
  • Vaccinations: Stay current on flu and pneumonia shots to prevent infections that can trigger decompensation (influenza; pneumococcal).
  • Heart-healthy habits: Don’t smoke, limit alcohol, prioritize sleep, and manage stress. See AHA guidance on activity with heart failure.

Living well with HFmrEF: practical tips

  • Make a simple “green-yellow-red” action plan with your care team (which changes or symptoms should prompt a call versus urgent care).
  • Use a pill organizer and phone reminders to take medicines consistently.
  • Bring your home blood pressure, heart rate, and weight logs to each visit.
  • Ask about telehealth or remote monitoring if travel is difficult.
  • Involve a dietitian to tailor sodium and fluid goals to your tastes and culture.

Questions to ask your clinician

  • What is my current EF, and how often should we recheck it?
  • Which medications are most important for me right now, and what side effects should I watch for?
  • Could blocked arteries, valve disease, or rhythm problems be contributing to my symptoms?
  • Do I qualify for cardiac rehab, and what type of exercise is safe?
  • What are my customized sodium and fluid targets?

When to seek urgent care

  • Severe or worsening shortness of breath, especially at rest
  • Chest pain or chest pressure that doesn’t go away
  • Fainting, confusion, or blue/pale lips or fingers
  • Fast weight gain (e.g., 2–3 pounds in a day) despite taking diuretics

Key takeaways

  • HFmrEF means your heart’s pumping function is mildly reduced (EF 41–49%) and deserves attention.
  • Early recognition of symptoms leads to faster treatment, fewer hospitalizations, and better quality of life.
  • Effective options include SGLT2 inhibitors, ACEi/ARB/ARNI, beta blockers, MRAs, diuretics, and targeted lifestyle changes.
  • Partner with your care team, track your symptoms and weight, and act quickly when things change.

This article is informational and not a substitute for professional medical advice. Always follow the guidance of your healthcare team.